Doppler Probe Use Is Cost Effective in Nonvariceal Upper GI Bleeding

This approach to evaluating high-risk stigmata reduced rebleeding and cost less than a traditional visual assessment.

Rebleeding after endoscopic hemostasis of nonvariceal upper gastrointestinal bleeding (NVUGIB) remains a major contributor to morbidity, mortality, and healthcare costs. Several studies show that a Doppler probe (DP) can be used to better assess endpoints of endoscopic treatment and provide more-durable therapy than traditional endoscopic visual assessment (TEA).

To compare the cost effectiveness of DP and TEA approaches in evaluating high-risk stigmata in patients with NVUGIB, researchers created a decision-tree model utilizing clinical probabilities from approximately 250 cases in two published randomized controlled trials. Effectiveness was the probability of rebleeding within 30 days. Sensitivity analyses incorporated a broad prefixed ra…

Reviewing Author

John R. Saltzman, MD

Disclosures

Consultant/Advisory BoardIterative Scopes

Editorial BoardsGastrointestinal Endoscopy; UpToDate

Leadership Positions in Professional SocietiesAmerican College of Gastroenterology (Trustee)

OtherVice President of Medical Affairs, 1Globe Health Institute